VYCEUM

Eli Lilly and Company

Application Filed: 2017-05-11
Trademark Application Details
Trademark Logo VYCEUM

Mark For: VYCEUM™ trademark registration is intended to cover the categories of pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hypoglycemia, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases.

Status

2021-07-25 UTC
DEAD APPLICATION Refused Dismissed or Invalidated
This trademark application was refused, dismissed, or invalidated by the Office and this application is no longer active.


Research OneLook Acronym Finder
Serial Number87446454
Mark Literal ElementsVYCEUM
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTrademark
Current LocationINTENT TO USE SECTION 2020-04-20
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameBruce W. Longbottom
Law Office AssignedL10
Employee NameLORENZO, GEORGE M

Timeline

2017-05-11Application Filed
2017-09-19Published
2017-09-19Published for Opposition
2018-05-16Location: INTENT TO USE SECTION
2019-10-14Status: Live/Pending
2019-10-16Transaction Date
2020-04-20Location: INTENT TO USE SECTION
2020-12-21Status: Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all docume

Trademark Parties (Applicants & Owners)

Party: Eli Lilly and Company
AddressLilly Corporate Center Indianapolis, INDIANA UNITED STATES 46285
Legal Entity TypeCorporation
Legal Entity StateINDIANA

Attorney of Record

BRUCE W. LONGBOTTOM
ELI LILLY AND COMPANY
LILLY CORPORATE CENTER
INDIANAPOLIS IN 46285

Good, Services, and Codes

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hypoglycemia, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases

Trademark Filing History

DescriptionDateProceeding Number
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED2020-12-21
ABANDONMENT - NO USE STATEMENT FILED2020-12-2199999
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2020-04-21
EXTENSION 5 GRANTED2020-04-2065362
TEAS EXTENSION RECEIVED2020-04-08
EXTENSION 5 FILED2020-04-0865362
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2019-10-16
TEAS EXTENSION RECEIVED2019-10-14
EXTENSION 4 GRANTED2019-10-1498765
EXTENSION 4 FILED2019-10-1498765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2019-04-11
TEAS EXTENSION RECEIVED2019-04-09
EXTENSION 3 GRANTED2019-04-0998765
EXTENSION 3 FILED2019-04-0998765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2018-10-20
TEAS EXTENSION RECEIVED2018-10-18
EXTENSION 2 GRANTED2018-10-1898765
EXTENSION 2 FILED2018-10-1898765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2018-05-17
EXTENSION 1 GRANTED2018-05-1665362
CASE ASSIGNED TO INTENT TO USE PARALEGAL2018-05-1665362
TEAS EXTENSION RECEIVED2018-05-01
EXTENSION 1 FILED2018-05-0165362
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2017-11-14
PUBLISHED FOR OPPOSITION2017-09-19
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2017-09-19
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2017-08-30
APPROVED FOR PUB - PRINCIPAL REGISTER2017-08-10
ASSIGNED TO EXAMINER2017-08-0973359
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2017-05-16
NEW APPLICATION ENTERED IN TRAM2017-05-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed